QUOTED. Jeff Shuren.
Jeff Shuren, director of the US FDA’s Device Center was recently quizzed by the House health subcommittee on why the new user-fee deal had reached Congress late, among other issues. See what Shuren said about it here.
“We are seeing the pipeline of innovative new devices in the US continues to become more robust, improving patient access to medical devices overall.” – Jeff Shuren, director, Center for Devices and Radiological Health, US FDA
Click here for a free trial of Medtech Insight